Gaucher disease, a condition that also results from a genetic mutation, and that like Pompe disease compels a lifetime of enzyme supplements, can serve as an example of what Pompe disease patients will face. People with Gaucher disease require more than NT $ 6 million for medication annually, allowing pharmaceutical firms to recover their initial outlays within a few years without difficulty.
以基因突變引起、同樣需要終生補充酵素的「高雪氏症」為例，每位患者一年用藥約需六百多萬元台幣，藥廠在短短幾年內回本不成問題。